Mirati Therapeutics to Participate in Two Upcoming Healthcare Conferences

SAN DIEGO, May 25, 2022 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will participate in two upcoming healthcare conferences. Thursday, June 9 at 10:00 a.m. ET / 7:00 a.m. PT at the Jefferies Healthcare Conference. David Meek, chief…

Click here to view original post